← Leaderboards
Gao Wang
Columbia University Health Sciences
$3,372,134
Attributed
$6,368,471
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2023–25$10M$7.5M$5M$2.5M$0
'23
'24
'25
Funding mix
By agency
NIH$6,368,471 · 3
By mechanism
R01$6,368,471 · 3
Top collaborators
- Julia Tcw2 shared
- Xin He1 shared
- Xiaoling Zhang1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Christopher Edward Mason$16,419,065
- Ana Navas-Acien$21,953,124
- Elizabeth Clarice Verna$4,269,042
- Andrea Baccarelli$24,279,074
- Julie Beth Herbstman$23,663,540
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposBrainS DiseaseCausal VariantQuantitative Trait LociPathogenesisGeneticComplexMolecular PhenotypeGenesMolecularGenome Wide Association StudyVariantMapsEtiologyInsightNovel StrategiesGenetic DiseasesData IntegrationMultiomic DataAtlasesCell TypeFunctional GenomicsGenetic Variant
Grant awards (6)
FunGen-xQTL: Unraveling the genetic basis of molecular functions in Alzheimer's Disease$3,642,232
R01 · FY2025 · AG · contact PI
Genetic Mapping of m6A and Pseudouridine RNA Modifications in the Aging Human Brain and Their Impact on Alzheimer's Disease$852,273
R01 · FY2025 · AG · contact PI
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers disease$586,390
R01 · FY2025 · AG · contact PI
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers disease$329,000
R01 · FY2025 · AG · contact PI
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers disease$446,886
R01 · FY2024 · AG · contact PI
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers disease$511,690
R01 · FY2023 · AG · contact PI